NEW YORK: THE U.S. government aims to begin offering COVID-19 vaccine booster shots widely next week to Americans age 16 and up. A panel of outside advisers to the Food and Drug Administration voted against such broad coverage on Friday but backed a shot for people 65 and older, which the agency may or may not follow.
President Joe Biden's administration faces criticism within the scientific community over whether the additional shots are needed for the general population.
WHAT DO THE DATA SAY ABOUT THE NEED FOR BOOSTERS?
Pfizer Inc and its German partner BioNTech SE, as well as rival vaccine maker Moderna Inc have each presented analyses of clinical trial data showing that the effectiveness of their shots, initially estimated at over 90% against symptomatic COVID-19 infection, wanes over time.
As a result, they say, people who were vaccinated earlier on in the pandemic are now more vulnerable to so-called breakthrough infections, particularly in the face of the fast-spreading Delta variant of coronavirus. Booster doses help restore the waning levels of antibodies produced by the original inoculation, the drugmakers have said.
Data from Pfizer's clinical trial of 30,000 people suggest that the vaccine's efficacy diminished by around 6% every two months after the second dose. In a second trial testing booster shots in 300 participants, a third dose generated a better immune response than the second, according to Pfizer.
Moderna this week said it found higher rates of breakthrough infection among participants in its clinical trial who received its two-dose vaccine roughly 13 months ago compared with those vaccinated roughly eight months ago. The study period was from July and August, when the highly-contagious Delta variant was the predominant strain.
U.S. health regulators are also closely watching real-world data on vaccine effectiveness and boosters from Israel, where a majority of the population has received the Pfizer/BioNTech vaccine. Israel is offering booster shots to everyone age 12 and up.
Israel's Health Ministry this week reported data showing that more than 1.1 million people aged 60 and older received a booster dose of Pfizer, resulting in a decline in overall infections as well as severe illness from COVID-19 in that group. The authors said their study suggests that a booster dose can restore vaccine efficacy among booster recipients to 95%.
In addition to preventing severe illness, some health officials in the United States and Israel say booster doses may help reduce transmission of the coronavirus at a time of rising infection rates in many countries.
WHAT IS THE CRITIQUE?
Many vaccine experts say the data so far only suggest a need for boosters in older adults and people with compromised immune systems. The critics include two FDA scientists who resigned as the United States government announced its booster shot plans.
For example, a report from Israel's Health Ministry shows a much higher risk of severe breakthrough infection among vaccinated people over the age of 60 compared with people aged 50-59 and 40-49, even though the younger groups include people who were vaccinated more than six months ago.
Other studies in the United States show that the vaccines remain highly protective against severe disease and death in adults under the age of 65.
Several other countries, including the UK, France and Germany, have so far limited booster plans to older adults and other high-risk groups.
The World Health Organization has repeatedly implored the United States and other wealthy countries to hold off on offering booster shots and to use those doses to help inoculate the many people worldwide who have yet to receive their first doses.
Scientists also say that there are confounding factors in analyzing waning vaccine effectiveness and the impact of boosters, including whether Delta may have a harsher impact on older adults and whether a return to mask-wearing in some places, rather than booster shots, is helping contain the spread.
They also say that randomized trials provide the best estimates of effectiveness in the real world, but most of the data so far is from observational studies or from small clinical trials.
Reuters
Sat Sep 18 2021
President Joe Biden's administration faces criticism within the scientific community over whether the additional shots are needed for the general population. -REUTERS
AWANI Ringkas: Protest bertembung dengan kumpulan pro-Israel
Ikuti rangkuman berita utama yang menjadi tumpuan sepanjang hari di Astro AWANI menerusi AWANI Ringkas.
Banyak usaha Kerajaan Perpaduan bantu masyarakat India - Fahmi
Menteri Komunikasi Fahmi Fadzil berkata banyak usaha dilakukan Kerajaan Perpaduan untuk membantu masyarakat India.
Kemalangan dua treler di lebuh raya, semua lorong arah utara terhalang
Susulan kemalangan itu menyebabkan semua lorong arah utara terhalang dan trafik dilencongkan ke Plaza Tol Kuala Kangsar.
Ketegangan terus memuncak di kampus A.S
Penunjuk perasaan terus berkumpul di kampus Universiti California Los Angeles (UCLA) selepas ketegangan memuncak di kampus A.S apabila penyokong pro-Israel menyerang perkhemahan penunjuk perasaan pro-Palestin pada Rabu.
Pelaburan Microsoft AS$2.2 bilion: Bukti keyakinan global kepada Malaysia - PM
Jumlah tersebut merupakan pelaburan terbesar pada satu-satu masa oleh Microsoft setelah 32 tahun bertapak di Malaysia.
[TERKINI] Pelaburan Microsoft jadikan Malaysia hab digital serantau
Kementerian Pelaburan, Perdagangan Dan Industri (MITI) dalam satu kenyataan menyambut baik pengumuman pelaburan oleh Microsoft.
Katanya, pelaburan itu bakal mempercepatkan transformasi digital negara seiring komitmen 'Bersama Malaysia' yang dilaksanakan Microsoft sejak tahun 2021.
Katanya, pelaburan itu bakal mempercepatkan transformasi digital negara seiring komitmen 'Bersama Malaysia' yang dilaksanakan Microsoft sejak tahun 2021.
[TERKINI] Microsoft umum pelaburan AI, awan bernilai USD2.2 bilion di Malaysia
Microsoft mengumumkan pelaburan 2.2 bilion dolar Amerika atau 10.48 bilion ringgit dalam Kecerdasan Buatan (AI) dan pembangunan infrastruktur awan di Malaysia.
Perkara itu diumumkan Pengerusi dan Ketua Pegawai Eksekutif (CEO) Microsoft Satya Nadella ketika memberi ucaptama mengenai era baharu Kecerdasan Buatan (AI) di Kuala Lumpur pada Khamis.
Perkara itu diumumkan Pengerusi dan Ketua Pegawai Eksekutif (CEO) Microsoft Satya Nadella ketika memberi ucaptama mengenai era baharu Kecerdasan Buatan (AI) di Kuala Lumpur pada Khamis.
Microsoft umum pelaburan AI, infrastruktur awan AS$2.2 bilion di Malaysia
Microsoft mengumumkan untuk melabur AS$2.2 bilion (RM10.48 bilion) dalam kecerdasan buatan (AI) dan pembangunan infrastruktur awan di Malaysia.
Tourism Malaysia jalin kerjasama dengan MAG bagi perkukuh misi TMM 2026
Tourism Malaysia memeterai Memorandum Persefahaman (MoU) dengan Malaysia Aviation Group (MAG) yang akan berlanjutan selama tiga tahun bagi mempromosikan Malaysia sebagai pilihan utama destinasi pelancongan dalam ekonomi global sempena Tahun Melawat Malaysia (TMM) 2026.
Tourism Malaysia laksana tiga strategi teras, tarik 35.6 juta pelancong
Tourism Malaysia melaksanakan tiga strategi teras bagi mempromosikan negara di peringkat antarabangsa serta domestik sempena Tahun Melawat Malaysia (TMM) 2026 merangkumi kewujudan permintaan, meningkatkan trafik dan mengutamakan pasaran sasaran.
COVID-19: Vaksin tetap beri perlindungan walau keberkesanan rendah terhadap mutasi baharu
Pakar penyakit berjangkit terkemuka Amerika Syarikat, Dr Anthony Fauci memberi saranan, bagi memastikan vaksin tersebut lebih berkesan, bilangan orang yang divaksin perlu ditingkatkan.
1MDB: Goldman Sachs potong pampasan tahunan CEOnya sebanyak RM70 juta
Lembaga syarikat turut mengekalkan gaji Solomon untuk tahun ini.
US poised to hit 16 million COVID-19 cases within days even as vaccine begins rollout
The United States is poised to hit a record 16 million COVID-19 cases in the coming days and deaths are closing in on the 300,000 mark.
Bintang US MasterChef Junior, Ben Watkins meninggal dunia pada usia 14 tahun
Bintang program realiti TV US MasterChef Junior, Ben Watkins dilaporkan meninggal dunia akibat penyakit kanser pada usia 14 tahun.
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita antarabangsa yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.
1MDB bayar US$681 juta kepada syarikat Aabar lain - Saksi
Shahrol Azral berkata pengarah juga tidak memberi sebarang persetujuan bagi pembayaran tersebut dikeluarkan daripada 1MDB Energy Holdings Limited kepada Aabar Seychelles.
Anak Beyonce, Blue Ivy tercalon Anugerah BET
Difahamkan, Blue Ivy Carter bakal bersaing bersama nama-nama tersohor yang lain seperti Lizzo, Alicia Keys, Lupita Nyongo, Missy Elliot, Ciara dan ramai lagi.
Insentif pemandu pelancong Johor cerminan keprihatinan kerajaan negeri
Pandemik COVID-19 telah melumpuhkan sektor pelancongan global dan Malaysia juga tidak terkecuali.
Bursa Malaysia di paras terendah sejak lebih 12 tahun
Bursa Malaysia mencecah tahap terendah pada 1,320.96 mata semasa dagangan Jumaat.
Jual pesawat khas presiden melalui loteri US$6 juta
Presiden Mexico yang baharu, Andres Manuel Lpez Obrador membuat kejutan apabila membuat pengumuman untuk menjual pesawat khas presiden melalui cabutan loteri.